SVRA Savara Inc
8-K Current Report
Filed: March 13, 2026
Health Care
Pharmaceutical PreparationsSavara Inc (SVRA) 8-K current report filed with SEC EDGAR on March 13, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 1.01: Entry into a Material Definitive Agreement
AI Filing Analysis8-K
Item 1.01 · Entry into a Material Definitive Agreement
- • HQ relocation to Yardley, PA (19 W. College Ave); ~10,795 sq ft leased from ML7 Yardley Partners
- • Lease term July 1, 2026 – Dec 1, 2031 with 5-year renewal option
Get deeper insights on Savara Inc
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.